Rocket One Inc. Common Stock (NASDAQ:RKTO) Announces Earnings Results

Rocket One Inc. Common Stock (NASDAQ:RKTO) posted its earnings results on Friday. The company reported ($0.19) EPS for the quarter, FiscalAI reports.

Rocket One Inc. Common Stock Trading Down 1.3%

RKTO opened at $0.76 on Friday. Rocket One Inc. Common Stock has a 1-year low of $0.49 and a 1-year high of $2.45. The stock has a market capitalization of $17.05 million, a price-to-earnings ratio of -0.93 and a beta of 0.96. The business has a 50 day moving average of $0.92 and a 200-day moving average of $0.91.

Hedge Funds Weigh In On Rocket One Inc. Common Stock

Institutional investors and hedge funds have recently bought and sold shares of the stock. Lido Advisors LLC bought a new stake in Rocket One Inc. Common Stock in the 3rd quarter valued at $32,000. Kestra Private Wealth Services LLC bought a new position in shares of Rocket One Inc. Common Stock during the 3rd quarter worth about $51,000. Geode Capital Management LLC increased its holdings in shares of Rocket One Inc. Common Stock by 8.0% during the 2nd quarter. Geode Capital Management LLC now owns 122,575 shares of the company’s stock worth $143,000 after purchasing an additional 9,071 shares during the period. Virtu Financial LLC acquired a new position in shares of Rocket One Inc. Common Stock during the third quarter valued at about $184,000. Finally, Citadel Advisors LLC bought a new stake in shares of Rocket One Inc. Common Stock in the third quarter valued at about $232,000. Institutional investors own 7.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the company. Wall Street Zen downgraded Rocket One Inc. Common Stock from a “sell” rating to a “strong sell” rating in a research note on Sunday. Weiss Ratings downgraded Rocket One Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, August 5th. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $5.00.

About Rocket One Inc. Common Stock

Hoth Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the acquisition, licensing and development of novel therapies for dermatological, central nervous system and other debilitating conditions. The company’s strategy emphasizes in-licensing late preclinical or early clinical assets with promising pharmacological profiles and leveraging formulation science to optimize delivery. Core to its approach is the design of topical and localized administration platforms intended to enhance drug penetration, sustain release and reduce systemic exposure.

Hoth’s development pipeline encompasses multiple candidate programs addressing high-unmet-need areas such as atopic dermatitis, epidermolysis bullosa and oral mucositis.